Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s share price rose 4.1% on Thursday . The company traded as high as $73.40 and last traded at $73.40. Approximately 135 shares changed hands during trading, a decline of 100% from the average daily volume of 106,239 shares. The stock had previously closed at $70.50.
ESTA has been the subject of a number of research analyst reports. BTIG Research raised their price objective on Establishment Labs from $41.00 to $61.00 and gave the company a “buy” rating in a research report on Wednesday, January 13th. Zacks Investment Research lowered Establishment Labs from a “buy” rating to a “hold” rating in a research report on Thursday, March 11th. Finally, Cowen raised their price objective on Establishment Labs from $60.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $47.60.
The company has a market cap of $1.63 billion, a PE ratio of -40.94 and a beta of 1.15. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.65 and a quick ratio of 5.24. The company has a 50-day moving average of $63.98 and a 200 day moving average of $43.36.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Lazard Asset Management LLC lifted its stake in Establishment Labs by 19.4% in the fourth quarter. Lazard Asset Management LLC now owns 2,633 shares of the company’s stock worth $99,000 after purchasing an additional 427 shares during the last quarter. BlackRock Inc. lifted its stake in Establishment Labs by 96.9% in the third quarter. BlackRock Inc. now owns 8,357 shares of the company’s stock worth $155,000 after purchasing an additional 4,113 shares during the last quarter. Squarepoint Ops LLC bought a new stake in Establishment Labs in the third quarter worth about $208,000. Trexquant Investment LP bought a new stake in Establishment Labs in the fourth quarter worth about $229,000. Finally, Tudor Investment Corp Et Al bought a new stake in Establishment Labs in the fourth quarter worth about $303,000. 54.80% of the stock is owned by institutional investors and hedge funds.
Establishment Labs Company Profile (NASDAQ:ESTA)
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution.
Read More: How Do You Calculate Return on Equity (ROE)?
Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.